BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2563233)

  • 1. Alterations in sleep polygraphy after neuroleptic withdrawal: a putative supersensitive dopaminergic mechanism.
    Thaker GK; Wagman AM; Kirkpatrick B; Tamminga CA
    Biol Psychiatry; 1989 Jan; 25(1):75-86. PubMed ID: 2563233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep polygraphy in schizophrenia: methodological issues.
    Thaker GK; Wagman AM; Tamminga CA
    Biol Psychiatry; 1990 Aug; 28(3):240-6. PubMed ID: 1974153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of neuroleptic withdrawal on plasma prolactin: a possible marker of receptor adaptation.
    Kirkpatrick B; Buchanan RW; Maeda K; Carpenter WT; Jauch D; Tamminga CA
    Biol Psychiatry; 1989 Jun; 26(2):131-8. PubMed ID: 2567610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of neuroleptic discontinuation on psychopathology, involuntary movements, and biochemical measures in patients with persistent tardive dyskinesia.
    Glazer WM; Bowers MB; Charney DS; Heninger GR
    Biol Psychiatry; 1989 Jul; 26(3):224-33. PubMed ID: 2568132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine effects of apomorphine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: relations to psychopathology and tardive dyskinesia.
    Müller-Spahn F; Ackenheil M; Albus M; May G; Naber D; Welter D; Zander K
    Psychopharmacology (Berl); 1984; 84(3):436-40. PubMed ID: 6151210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroencephalographic sleep in clinically stable schizophrenic patients: two-weeks versus six-weeks neuroleptic-free.
    Nofzinger EA; van Kammen DP; Gilbertson MW; Gurklis JA; Peters JL
    Biol Psychiatry; 1993 Jun 1-15; 33(11-12):829-35. PubMed ID: 8104041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep in schizophrenic patients on and off haloperidol therapy. Clinically stable vs relapsed patients.
    Neylan TC; van Kammen DP; Kelley ME; Peters JL
    Arch Gen Psychiatry; 1992 Aug; 49(8):643-9. PubMed ID: 1637254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic withdrawal in treatment-resistant patients with schizophrenia: tardive dyskinesia is not associated with supersensitive psychosis.
    Apud JA; Egan MF; Wyatt RJ
    Schizophr Res; 2003 Sep; 63(1-2):151-60. PubMed ID: 12892869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal prolactin responses in tardive dyskinesia.
    Asnis GM; Sachar EJ; Langer G; Halpern FS; Fink M
    Psychopharmacology (Berl); 1979; 66(3):247-50. PubMed ID: 43550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic-induced supersensitivity psychosis.
    Chouinard G; Jones BD; Annable L
    Am J Psychiatry; 1978 Nov; 135(11):1409-10. PubMed ID: 30291
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroleptic plasma levels and tardive dyskinesia: a possible link?
    Nasrallah HA
    Schizophr Bull; 1980; 6(1):4-7. PubMed ID: 6102792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molindone and haloperidol in tardive dyskinesia.
    Glazer WM; Hafez HM; Benarroche CL
    J Clin Psychiatry; 1985 Aug; 46(8 Pt 2):4-7. PubMed ID: 2862139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin shifts after neuroleptic withdrawal.
    Green AI; Faraone SV; Brown WA
    Psychiatry Res; 1990 Jun; 32(3):213-9. PubMed ID: 1975101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of neuroleptic treatment on polysomnographic measures in schizophrenia.
    Taylor SF; Tandon R; Shipley JE; Eiser AS
    Biol Psychiatry; 1991 Nov; 30(9):904-12. PubMed ID: 1684117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rebound insomnia in neuroleptic drug withdrawal neurophysiologic characteristics.
    van Sweden B
    Pharmacopsychiatry; 1987 May; 20(3):116-9. PubMed ID: 2885865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiological mechanisms underlying tardive dyskinesia.
    Gerlach J
    Psychopharmacology Suppl; 1985; 2():98-103. PubMed ID: 2860666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The electroencephalographic sleep pattern in schizophrenic patients treated with clozapine or classical antipsychotic drugs.
    Wetter TC; Lauer CJ; Gillich G; Pollmächer T
    J Psychiatr Res; 1996; 30(6):411-9. PubMed ID: 9023785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of dopaminergic supersensitivity induced by neuroleptic drugs in mice.
    Yen-Koo HC; Balazs T
    Drug Chem Toxicol; 1980; 3(2):237-47. PubMed ID: 6112126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. REM-latency in neuroleptic drug withdrawal. A case report.
    Van Sweden B
    Acta Psychiatr Belg; 1984; 84(3):235-9. PubMed ID: 6148841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.
    Schultz SK; Miller DD; Arndt S; Ziebell S; Gupta S; Andreasen NC
    Biol Psychiatry; 1995 Dec; 38(11):713-9. PubMed ID: 8580223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.